Chronic News and Research

RSS

Pharmasset initiates dosing in PSI-7977 exploratory study in HCV

Pharmasset, Inc. announced today that dosing has begun in an exploratory study of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 400mg QD in combination with ribavirin (RBV), with 0, 4, 8, or 12 weeks of pegylated interferon alfa 2a (Peg-IFN) in treatment-naive patients infected with HCV genotype 2 or 3.

14 Dec 2010

We live longer, but not healthier

Increased life expectancy in the United States has not been accompanied by more years of perfect health, reveals new research published in the December issue of the Journal of Gerontology.

14 Dec 2010

The Affordable Care Act can benefit 18.3 million men and women ages 50 to 64

18.3 million men and women ages 50 to 64 stand to benefit from provisions in the Affordable Care Act, assure that all health insurance provides a standard comprehensive benefit, prevent insurers from denying coverage or charging higher premiums to people with pre-existing conditions, and eliminate lifetime and annual limits in health insurance policies, according to a new Commonwealth Fund report released today.

14 Dec 2010

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.

14 Dec 2010

SINTEF ICT scientists develop sensor belt to monitor chronically ill patients

SINTEF ICT scientists have developed a sensor belt that monitors chronically ill patients and communicates the results via mobile telephone. The scientists are now about to carry out a user trial together with a research partner in the US.

14 Dec 2010

Go Daddy gifts $500,000 to Southwest Center for HIV/AIDS to launch Women's Health Center in Phoenix

Southwest Center for HIV/AIDS received $500,000 from Go Daddy to launch the Go Daddy Women's Health Center in Phoenix. The gift was announced by Go Daddy CEO and Founder Bob Parsons at the company's annual holiday event held Saturday, December 11 at Chase Field in Phoenix. Parsons presented a 'big check' to Carol Poore, President and CEO, Southwest Center for HIV/AIDS.

14 Dec 2010

Research: Kidney disease caused by autoimmune disease lupus may be twice as lethal in children

Kidney disease caused by the autoimmune disease lupus may be twice as lethal in children as kidney disease caused by other disorders, according to research led by Johns Hopkins Children's Center investigators.

13 Dec 2010

WellDoc DiabetesManager solution integrated with leading EHR system

WellDoc®, a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs, today announced the first integration of a clinically tested mHealth coaching platform with a leading electronic health records (EHR) system. The integration of the WellDoc DiabetesManager® solution into an EHR will streamline and enhance patient care by combining a best-in-class patient coaching platform and clinical decision support with the workflow efficiency of an EHR system.

13 Dec 2010

iTech Medical receives Health Canada approval for Muscle Pattern Recognition System

iTech Medical, Inc., a medical information technology company, announced today that it has received Health Canada approval for the Company's Muscle Pattern Recognition (MPR) System, a non-invasive clinical assessment tool being developed to assist in the diagnosis and treatment of back and neck pain, one of the most common chronic conditions in Canada.

13 Dec 2010

U-M's participation in Medicare Physician Group Practice Demonstration Project helps save over $15 million

Medicare patients with a host of physical problems are getting better care at the University of Michigan Health System, and U-M staff have saved more than $15 million on the cost of that care over four years.

13 Dec 2010

Combination of SPECT and CT scans could offer protection against lymphedema in breast cancer patients

With guidance from a specialized scan, radiation oncologists at Mayo Clinic were able to reduce by 55 percent the number of lymph nodes critical for removing fluid from the arm that received damaging radiation doses.

13 Dec 2010

Depression drug appears effective in reducing pain associated with breast cancer treatment

A drug commonly used to treat depression and anxiety disorder was effective at reducing joint and muscle pain associated with a breast cancer treatment, according to a study from the University of Michigan Comprehensive Cancer Center.

12 Dec 2010

OpEds: Palin on the Ryan Roadmap, Seniors and primary care docs, Arizona transplant controversy

[The president's National Commission on Fiscal Responsibility and Reform's report] implicitly endorses the use of 'death panel'-like rationing by way of the new Independent Payments Advisory Board—making bureaucrats, not medical professionals, the ultimate arbiters of what types of treatment will (and especially will not) be reimbursed under Medicare.

10 Dec 2010

Stroke falls from third to fourth leading cause of death

A new report, "Deaths: Preliminary Data for 2008," released by the Centers for Disease Control and Prevention (CDC), says that for the first time in 50 years, stroke has fallen from the third to the fourth leading cause of death.

10 Dec 2010

Aastrom Biosciences prices public offering

Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that it has priced a public offering of 10,000,000 units, with each unit consisting of one share of the Company's common stock and one warrant to purchase one share of common stock, at a purchase price of $2.25 per unit for an aggregate offering amount of $22.5 million.

10 Dec 2010

31-year-old mother with Gorham-Stout syndrome goes home with virtually rebuilt spine

Laurie Harms, Los Angeles, feared she'd never hold her infant daughter, Sky, again. A devastating and extremely rare bone-eroding disease - Gorham-Stout syndrome - had left the 31-year-old crumpled in a hospital bed - her neck broken, arms limp and useless, and voice muted by tubes.

10 Dec 2010

COPD becomes third leading cause of death in the U.S.

The Centers for Disease Control (CDC) and Prevention's National Center for Health Statistics (NCHS) released a report today, "Deaths: Preliminary Data for 2008," confirming that Chronic Obstructive Pulmonary Disease (COPD) became the third leading cause of death in the U.S. for 2008.

10 Dec 2010

Exposure to tobacco smoke causes immediate damage leading to serious illness or death

Exposure to tobacco smoke - even occasional smoking or secondhand smoke - causes immediate damage to your body that can lead to serious illness or death, according to a report released today by U.S. Surgeon General Regina M. Benjamin. The comprehensive scientific report - Benjamin's first Surgeon General's report and the 30th tobacco-related Surgeon General's report issued since 1964 - describes specific pathways by which tobacco smoke damages the human body and leads to disease and death.

10 Dec 2010

Talecris initiates clinical trial to evaluate 2 doses of PROLASTIN-C for emphysema due to AAT deficiency

Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.

10 Dec 2010

Clinical, preclinical results of ISF35 in CLL patients presented at ASH 2010

Memgen, LLC announced the presentation of clinical and preclinical results for its lead product, ISF35, during the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The research and clinical development of ISF35 announced today was led by Januario Castro, MD, and Thomas Kipps, MD, PhD, both at the University of California, San Diego.

10 Dec 2010

Chronic News and Research

Pharmasset initiates dosing in PSI-7977 exploratory study in HCV

We live longer, but not healthier

The Affordable Care Act can benefit 18.3 million men and women ages 50 to 64

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

SINTEF ICT scientists develop sensor belt to monitor chronically ill patients

Go Daddy gifts $500,000 to Southwest Center for HIV/AIDS to launch Women's Health Center in Phoenix

Research: Kidney disease caused by autoimmune disease lupus may be twice as lethal in children

WellDoc DiabetesManager solution integrated with leading EHR system

iTech Medical receives Health Canada approval for Muscle Pattern Recognition System

U-M's participation in Medicare Physician Group Practice Demonstration Project helps save over $15 million

Combination of SPECT and CT scans could offer protection against lymphedema in breast cancer patients

Depression drug appears effective in reducing pain associated with breast cancer treatment

OpEds: Palin on the Ryan Roadmap, Seniors and primary care docs, Arizona transplant controversy

Stroke falls from third to fourth leading cause of death

Aastrom Biosciences prices public offering

31-year-old mother with Gorham-Stout syndrome goes home with virtually rebuilt spine

COPD becomes third leading cause of death in the U.S.

Exposure to tobacco smoke causes immediate damage leading to serious illness or death

Talecris initiates clinical trial to evaluate 2 doses of PROLASTIN-C for emphysema due to AAT deficiency

Clinical, preclinical results of ISF35 in CLL patients presented at ASH 2010

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News